• Dr. Jutras-Aswad, lead investigator for this trial, added, "This is an important investigation for a disorder that causes morbidity, mortality, and has significant social impact. (azbio.org)
  • However, tolerance and the risk for cannabis use disorder are two significant disadvantages for cannabinoid-based therapies in humans. (bvsalud.org)